Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities
Net income	$ 7,674	$ 5,074
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation	153	189
Right of use asset amortization	346	333
Provision for loan losses		2,365
Share-based compensation expense	139	149
Net amortization of securities	125	95
Fair value adjustment on equity securities	117	(33)
Amortization of debt issuance costs	117	13
Net losses on premises and equipment	1
Gains on sales and calls of available-for-sale securities		(10)
Deferred tax expense (benefit)	580	(835)
Increase in cash surrender value of life insurance	(95)	(107)
Changes in assets and liabilities:
Decrease in accrued interest receivable	589	490
Decrease in other assets	409	583
Decrease in accrued interest payable	(366)	(185)
Increase (decrease) in other liabilities	(172)	571
Net cash provided by operating activities	9,617	8,692
Cash Flows from Investing Activities
Net (increase) decrease in loans	35,208	(43,260)
Purchase of available-for-sale securities	(87,151)	(71,807)
Purchase of held-to-maturity securities	(1,003)
Proceeds from sales of available-for-sale securities	0	0
Proceeds from maturities, calls and principal repayments of available-for-sale securities	14,968	7,831
Proceeds from maturities, calls and principal repayments of held-to-maturity securities	2,261
Net (purchase) redemption of restricted securities	(137)	587
Purchase of equity securities	(572)	(455)
Purchases of bank premises and equipment	(66)	(70)
Net cash (used in) investing activities	(36,492)	(107,174)
Cash Flows from Financing Activities
Net increase in deposits	101,546	121,270
Issuance of common stock for share options exercised	1,891	152
Net cash provided by investing activities	103,437	121,422
Net increase in cash and cash equivalents	76,562	22,940
Cash and cash equivalents, beginning of period	105,799	138,457
Cash and cash equivalents, end of period	182,361	161,397
Supplemental Disclosures of Cash Flow Information
Interest	2,078	2,637
Supplemental Disclosures of Noncash Transactions
Unrealized gain (loss) on securities available-for-sale	$ (13,276)	$ (3,229)